Stents Market Size, Share & Trends Analysis Report By Product (Vascular, Non-vascular), By Material (Metallic, Non-metallic), By End-use (Hospitals, Ambulatory Care Centers, Specialty Clinics), By Region, And Segment Forecasts, 2024 - 2030

Stents Market Size, Share & Trends Analysis Report By Product (Vascular, Non-vascular), By Material (Metallic, Non-metallic), By End-use (Hospitals, Ambulatory Care Centers, Specialty Clinics), By Region, And Segment Forecasts, 2024 - 2030


Stents Market Growth & Trends

The global stents market size is expected to reach USD 18.46 billion by 2030, registering a CAGR of 3.8% from 2024 to 2030, according to a new report by Grand View Research, Inc. The market's growth can be attributed to the increasing prevalence of chronic diseases, such as peripheral vascular diseases (PVDs) and coronary artery diseases (CAD). As per the American Heart Association (AHA) and their Heart Disease and Stroke Statistics - 2022 Update, cardiovascular disease (CVD) was responsible for around 19.05 million global fatalities.

Moreover, according to estimates by the European Commission, the number of new cancer cases is expected to reach 2.74 million in 2022, a 2.3% increase from 2020. Additionally, cancer deaths are predicted to rise by 2.4% when compared to 2020. As per the Australian Institute of Health and Welfare report, there were 25,000 hospitalizations for asthma in 2020-21, with a rate of 100 per 100,000 population. The rate among children aged 0-14 was significantly higher at 225 compared to 68 for those over 15. The escalating prevalence of chronic diseases is expected to boost the demand for stents.

Furthermore, physical inactivity, smoking, and chronic stress, among others, can collectively contribute to the development of chronic diseases. For instance, according to the Centers for Disease Control and Prevention (CDC) report, smoking is responsible for around 90% of lung cancer-related deaths and about 80% of chronic obstructive pulmonary disease (COPD) deaths. Additionally, the increasing adoption of unhealthy lifestyles is expected to escalate the market growth.

As per the CDC report, in 2021, approximately 11.5% of U.S. adults aged 18 years or older, which amounts to almost 12 out of every 100 people, are smokers. This indicates that an estimated 28.3 million adults residing in the U.S. smoke cigarettes. Additionally, more than 16 million Americans are affected by smoking-related diseases. This indicated the growing demand for the market. Moreover, the increasing initiatives undertaken by key market players will supplement market growth. In April 2023, Terumo started a new clinical study for the Ultimaster Nagomi sirolimus-eluting coronary stent system in patients undergoing complex PCI.

Stents Market Report Highlights
  • Based on product, the vascular stents segment dominated the market in 2023, holding the largest share of 88.40%. The increasing prevalence of cardiovascular diseases is anticipated to escalate market growth
  • Based on material, the metallic stents segment held a significant share of 62.10% in the market in 2023. Increasing research and development activities in stents is expected to boost market growth. Moreover, the increasing preference for minimally invasive procedures further fueled the segment's growth
  • Based on end-use, hospitals dominated the market in 2023, representing the largest share of 74.24%. Increasing emphasis on value-based healthcare and the expanding demand for percutaneous coronary intervention are escalating the market growth
  • North America emerged as the leading region in 2023, holding the largest share of 43.69%. The increasing prevalence of lifestyle-related chronic diseases within the region, such as coronary artery disease and peripheral arterial disease, will supplement market growth
Please note The report will be delivered in 2-3 business days upon order notification.


Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Market Definitions
1.3. Information Procurement
1.3.1. Purchased Database
1.3.2. GVR’s Internal Database
1.3.3. Secondary Sources & Third-Party Perspectives
1.3.4. Primary Research
1.3.5. Details of Primary Research
1.4. Information Analysis
1.4.1. Data Analysis Models
1.5. Market Formulation & Data Visualization
1.5.1. Commodity Flow Analysis
1.5.1.1. Approach 1: Commodity flow approach
1.6. Data Validation & Publishing
1.7. Global Market: CAGR Calculation
1.8. List of Secondary Sources
1.9. List of Primary Sources
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Trends and Outlook
3.3. Market Dynamics
3.4. Market Restraint Analysis
3.5. Business Environment Analysis
3.5.1. SWOT Analysis; By Factor (Political & Legal, Economic and Technological)
3.5.2. Porter’s Five Forces Analysis
3.6. COVID-19 Impact Analysis
Chapter 4. Product Business Analysis
4.1. Stents Market, By Product: Key Takeaways
4.2. Stents Market: Product Movement & Market Share Analysis, 2022 & 2030
4.3. Vascular Stents
4.3.1. Global Vascular Stents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.2. Coronary Stents
4.3.2.1. Global Coronary Stents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.3. Peripheral Stents
4.3.3.1. Global Peripheral Stents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.3.2. Iliac Artery Stents
4.3.3.2.1. Global Iliac Artery Stents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.3.3. Femoral Artery Stents
4.3.3.3.1. Global Femoral Artery Stents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.3.4. Carotid Artery Stents
4.3.3.4.1. Global Carotid Artery Stents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.3.5. Renal Artery Stents
4.3.3.5.1. Global Renal Artery Stents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.3.6. Other Peripheral Stents
4.3.3.6.1. Global Other Peripheral Stents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.4. Neurovascular Stents
4.3.4.1. Global Neurovascular Stents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.4.2. Intracranial Stents
4.3.4.2.1. Global Intracranial Stents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.4.3. Flow Diverters
4.3.4.3.1. Global Flow Diverters Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4. Non-vascular Stents
4.4.1. Global Non-vascular Stents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.2. Gastrointestinal Stents
4.4.2.1. Global Gastrointestinal Stents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.2.2. Biliary
4.4.2.2.1. Global Biliary Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.2.3. Duodenal
4.4.2.3.1. Global Duodenal Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.2.4. Colonic
4.4.2.4.1. Global Colonic Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.2.5. Pancreatic
4.4.2.5.1. Global Pancreatic Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.2.6. Esophageal Stents
4.4.2.6.1. Global Esophageal Stents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.3. Pulmonary (Airway) Stents
4.4.3.1. Global Pulmonary (Airway) Stents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.3.2. Silicone Airway
4.4.3.2.1. Global Silicone Airway Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.3.3. Metallic Airway
4.4.3.3.1. Global Metallic Airway Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.4. Urological Stents
4.4.4.1. Global Urological Stents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.5. Others
4.4.5.1. Global Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. Material Business Analysis
5.1. Stents Market, By Material: Key Takeaways
5.2. Stents Market: Material Movement & Market Share Analysis, 2022 & 2030
5.3. Metallic Stents
5.3.1. Global Metallic Stents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4. Non-metallic Stents
5.4.1. Global Non-metallic Stents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 6. End-Use Business Analysis
6.1. Stents Market, By End-use: Key Takeaways
6.2. Stents Market: End-use Movement & Market Share Analysis, 2022 & 2030
6.3. Hospitals
6.3.1. Global Hospitals Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4. Ambulatory Care Centers (ACS)
6.4.1. Global Ambulatory Care Centers (ACS) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5. Specialty Clinics
6.5.1. Global Specialty Clinics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 7. Regional Business Analysis
7.1. Regional Market Snapshot
7.2. Market Share Analysis by Country, 2022
7.2.1. North America
7.2.2. Europe
7.2.3. Asia Pacific
7.2.4. Latin America
7.2.5. MEA
7.3. North America
7.3.1. North America Stents Market, 2018 - 2030 (USD Million)
7.3.2. U.S.
7.3.2.1. U.S. Stents Market, 2018 - 2030 (USD Million)
7.3.3. Canada
7.3.3.1. Canada Stents Market, 2018 - 2030 (USD Million)
7.4. Europe
7.4.1. Europe Stents Market, 2018 - 2030 (USD Million)
7.4.2. Germany
7.4.2.1. Germany Stents Market, 2018 - 2030 (USD Million)
7.4.3. UK
7.4.3.1. UK Stents Market, 2018 - 2030 (USD Million)
7.4.4. France
7.4.4.1. France Stents Market, 2018 - 2030 (USD Million)
7.4.5. Italy
7.4.5.1. Italy Stents Market, 2018 - 2030 (USD Million)
7.4.6. Spain
7.4.6.1. Spain Stents Market, 2018 - 2030 (USD Million)
7.4.7. Denmark
7.4.7.1. Denmark Stents Market, 2018 - 2030 (USD Million)
7.4.8. Sweden
7.4.8.1. Sweden Stents Market, 2018 - 2030 (USD Million)
7.4.9. Norway
7.4.9.1. Norway Stents Market, 2018 - 2030 (USD Million)
7.5. Asia Pacific
7.5.1. Asia Pacific Stents Market, 2018 - 2030 (USD Million)
7.5.2. Japan
7.5.2.1. Japan Stents Market, 2018 - 2030 (USD Million)
7.5.3. China
7.5.3.1. China Stents Market, 2018 - 2030 (USD Million)
7.5.4. India
7.5.4.1. India Stents Market, 2018 - 2030 (USD Million)
7.5.5. South Korea
7.5.5.1. South Korea Stents Market, 2018 - 2030 (USD Million)
7.5.6. Australia
7.5.6.1. Australia Stents Market, 2018 - 2030 (USD Million)
7.5.7. Thailand
7.5.7.1. Thailand Stents Market, 2018 - 2030 (USD Million)
7.6. Latin America
7.6.1. Latin America Stents Market, 2018 - 2030 (USD Million)
7.6.2. Brazil
7.6.2.1. Brazil Stents Market, 2018 - 2030 (USD Million)
7.6.3. Mexico
7.6.3.1. Mexico Stents Market, 2018 - 2030 (USD Million)
7.6.4. Argentina
7.6.4.1. Argentina Stents Market, 2018 - 2030 (USD Million)
7.7. MEA
7.7.1. MEA Stents Market, 2018 - 2030 (USD Million)
7.7.2. South Africa
7.7.2.1. South Africa Stents Market, 2018 - 2030 (USD Million)
7.7.3. Saudi Arabia
7.7.3.1. Saudi Arabia Stents Market, 2018 - 2030 (USD Million)
7.7.4. UAE
7.7.4.1. UAE Stents Market, 2018 - 2030 (USD Million)
7.7.5. Kuwait
7.7.5.1. Kuwait Stents Market, 2018 - 2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Company Categorization
8.2. Strategy Mapping
8.3. Company Profiles/Listing
8.3.1. Abbott Laboratories
8.3.1.1. Overview
8.3.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.3.1.3. Product Benchmarking
8.3.1.4. Strategic Initiatives
8.3.2. B. Braun Melsungen AG
8.3.2.1. Overview
8.3.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.3.2.3. Product Benchmarking
8.3.2.4. Strategic Initiatives
8.3.3. Biotronik SE & Co. KG
8.3.3.1. Overview
8.3.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.3.3.3. Product Benchmarking
8.3.3.4. Strategic Initiatives
8.3.4. Biosensors International Group, Ltd.
8.3.4.1. Overview
8.3.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.3.4.3. Product Benchmarking
8.3.4.4. Strategic Initiatives
8.3.5. Boston Scientific Corporation
8.3.5.1. Overview
8.3.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.3.5.3. Product Benchmarking
8.3.5.4. Strategic Initiatives
8.3.6. Elixir Medical Corporation
8.3.6.1. Overview
8.3.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.3.6.3. Product Benchmarking
8.3.6.4. Strategic Initiatives
8.3.7. Medtronic Plc
8.3.7.1. Overview
8.3.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.3.7.3. Product Benchmarking
8.3.7.4. Strategic Initiatives
8.3.8. Meril Life Science
8.3.8.1. Company Overview
8.3.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.3.8.3. Platform Benchmarking
8.3.8.4. Strategic Initiatives
8.3.9. MicroPort Scientific Corporation
8.3.9.1. Company Overview
8.3.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.3.9.3. Platform Benchmarking
8.3.9.4. Strategic Initiatives
8.3.10. Stryker
8.3.10.1. Company Overview
8.3.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.3.10.3. Platform Benchmarking
8.3.10.4. Strategic Initiatives
8.3.11. Terumo Corporation
8.3.11.1. Company Overview
8.3.11.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.3.11.3. Platform Benchmarking
8.3.11.4. Strategic Initiatives
8.3.12. BD
8.3.12.1. Company Overview
8.3.12.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.3.12.3. Platform Benchmarking
8.3.12.4. Strategic Initiatives
8.3.13. W.L Gore & Associates
8.3.13.1. Company Overview
8.3.13.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.3.13.3. Platform Benchmarking
8.3.13.4. Strategic Initiatives

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings